Innocoll has secured European approval for its CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery.
CollaGUARD is a transparent bioresorbable film of 100% type I collagen, developed using Innocoll’s proprietary CollaFilm technology.
The adhesion barrier is implanted at the time of surgery and serves as a temporary barrier to separate apposing adhesiogenic surfaces throughout the normal tissue repair process.
When tested in vivo, CollaGUARD increased the probability of remaining adhesion-free by more than six-fold, and reduced the extent and severity of adhesions.
The company also plans to seek approval in Australia, Canada, the Middle East, North Africa and south-east Asia.
It will also initiate the studies required for registration in the US.
